Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Are you being bribed? Health care ethics and compliance in the AdvaMed Code era. Part II.

Byrd AB, Tearney MB.

Am J Orthop (Belle Mead NJ). 2006 Apr;35(4):166-71. No abstract available.

PMID:
16689513
3.

Are you being bribed? Health care ethics and compliance in the AdvaMed code era. Part I.

Byrd AB, Tearney MB.

Am J Orthop (Belle Mead NJ). 2006 Mar;35(3):117-20. Review. No abstract available.

PMID:
16610375

Supplemental Content

Loading ...
Write to the Help Desk